LKT Labs

Biochemicals for Life Science Research

Homoharringtonine

Homoharringtonine

Product ID H5750
Cas No. 26833-87-4
Purity ≥97%
Product Unit SizeCostQuantityStock
1 mg $44.80 In stock
5 mg $126.80 In stock
10 mg $154.40 In stock
Bulk Quote

Quicklinks

Description

Homoharringtonine is an alkaloid found in Cephalotaxus that binds the A site of the 60 S ribosomal subunit, preventing aminoacyl-tRNA binding, inhibiting protein translation, and inducing cell death; it exhibits anticancer chemotherapeutic and immunosuppressive activities. Homoharringtonine is clinically used to treat chronic myelogenous leukemia (CML) and is currently in clinical trials as a potential treatment for acute myelogenous leukemia (AML) and myelodysplastic syndrome. In clinical subjects, homoharringtonine decreases the number of CD34+, CD117+ cells.

Product Info

Cas No.

26833-87-4
Purity

≥97%
Formula

C29H39NO9
Formula Wt.

545.62
Melting Point

143-145°C
Solubility

Soluble in DMSO (50 mg/mL), ethanol (25 mg/mL). Slightly soluble in chloroform, methanol.
Appearance

White Powder

Shipping and Storage

Store Temp

-20°C
Ship Temp

Ambient

Downloads

MSDS

H5750 MSDS PDF
Info Sheet

H5750 Info Sheet PDF
Brochures

Natural Products Booklet

References

Gandhi V, Plunkett W, Cortes JE. Omacetaxine: a protein translation inhibitor for treatment of chronic myelogenous leukemia. Clin Cancer Res. 2014 Apr 1;20(7):1735-40. PMID: 24501394.

Daver N, Vega-Ruiz A, Kantarjian HM, et al. A phase II open-label study of the intravenous administration of homoharringtonine in the treatment of myelodysplastic syndrome. Eur J Cancer Care (Engl). 2013 Sep;22(5):605-11. PMID: 23701251.

Li YF, Deng Z, Din BH, et al. Effect of homoharringtonine on bone marrow CD34 + CD117 + cells in patients with chronic myelogenous leukemia. Leuk Lymphoma. 2012 May;53(5):934-9. PMID: 22054289.

Custom Order

  • Size of single unit expressed as number (e.g. '500' in the case of 500 mg)
  • Total quantity of unit size desired (e.g. '10' in the case of 10 x 500 mg). If only one unit is desired, you may leave this blank.
  • This field is for validation purposes and should be left unchanged.

Related Products

  • E6996

    Erythromycin Thiocyanate

    Macrolide; protein translation inhibitor, mammalia...
    ≥90%
  • L1881

    Leuprolide Acetate

    GnRH analog; GnRH1 agonist.
    ≥98%
  • A7672

    Atropine Sulfate Monohydrate

    Tropane alkaloid found in Solanaceae plants; mAChR...
    ≥98%
  • I0516

    I-BET151

    BRD2/3/4 inhibitor.
    ≥98%
  • A6800

    AR-A014418

    GSK-3β inhibitor.
    ≥98%
  • A5070

    Angiotensin Acetate

    Peptide, derivative of AT I, cleavage product of a...
    ≥95%
  • S9775

    Systemin

    Peptide hormone found in Solanaceae family plants;...
    ≥95%
  • N1995

    Neurotensin, guinea pig

    Endogenous neuropeptide involved in hormone releas...
    ≥95%
  • Y4800

    YM-155

    Survivin inhibitor.
    ≥99%
  • E9819

    Ezetimibe

    NPC1L1 inhibitor.
    ≥99%
  • M1749

    Memantine Hydrochloride

    D2 agonist, NMDA, 5-HT3, α7 nAChR antagonist.
    ≥97%
  • P7103

    Praziquantel

    Alters membrane permeability and Ca2+ signaling; p...
    ≥98%
  • A0002

    A66

    p110α PI3K inhibitor.
    ≥98%
  • B0026

    Bafilomycin B1

    Macrolide; vacuolar H+-ATPase inhibitor.
    ≥97%
  • E6232

    (−)-Epicatechin Gallate

    Flavanol originally found in Camilla (green tea); ...
    ≥98%
  • G6802

    Granisetron Hydrochloride

    5-HT3 antagonist.
    ≥98%
  • C9881

    Cytochalasin D

    Mycotoxin produced by Aspergillus; actin polymeriz...
    ≥98%
  • P6232

    PP-1

    Src inhibitor.
    ≥98%
  • A044178

    Abemaciclib mesylate

    CDK inhibitor.
    ≥98%
  • R1626

    Regorafenib Monohydrate

    VEGFR1/2/3, TIE2, PDGFRβ, FGFR1, c-Kit, RET, B-Ra...
    ≥99%